Valuation: Teyi Pharmaceutical Group Co.,Ltd

Market Cap 4.68B 690M 603M 554M 516M 980M 65.66B 994M 6.65B 2.59B 32.28B 2.59B 2.53B 111B P/E 2024
224x
P/E 2025 67.8x
Enterprise Value 4.61B 679M 594M 545M 508M 964M 64.64B 979M 6.55B 2.55B 31.78B 2.55B 2.49B 109B EV / Sales 2024
6.57x
EV / Sales 2025 5.78x
Free-Float
60.48%
Yield 2024
0.56%
Yield 2025 1.38%
1 day-0.21%
1 week+17.12%
Current month+2.40%
1 month+8.20%
3 months-14.82%
6 months-13.64%
Current year-13.64%
1 week 7.99
Extreme 7.99
10.04
1 month 7.66
Extreme 7.66
10.04
Current year 7.66
Extreme 7.66
14.47
1 year 7.66
Extreme 7.66
15.21
3 years 6.79
Extreme 6.79
17.49
5 years 5.64
Extreme 5.6429
19.64
10 years 5.01
Extreme 5.0102
20.4
Manager TitleAgeSince
Chief Executive Officer 34 2025-07-15
Director of Finance/CFO 54 2009-06-14
Corporate Officer/Principal 43 2020-05-31
Director TitleAgeSince
Director/Board Member 54 2009-06-14
Director/Board Member 43 2022-06-26
Chairman 34 2025-07-15
Date Insider Type Main position Quantity % Market Cap.
24-02-06Buy

Chief Financial Officer

42,000 0.0188%
23-06-13Buy

Chief Financial Officer

42,000 0.0188%
Change 5-day change 1-year change 3-year change Capi.($)
-0.21%+17.12%+7.45%-14.21% 690M
+1.86%+0.48%+55.50%+163.08% 1,082B
+3.57%+3.29%+68.60%+61.03% 633B
+3.99%+3.05%+37.93%+93.37% 461B
+3.86%+1.64%+32.57%+24.89% 338B
-0.56%+0.96%+41.67%+39.35% 299B
-0.08%+1.30%+32.15%+44.48% 291B
-1.54%+2.81%-25.35%-39.61% 222B
+3.55%+4.41%+25.45%+66.28% 202B
+4.21%+2.65%+17.47%+71.11% 163B
Average +1.87%+4.77%+29.34%+50.98% 369.31B
Weighted average by Cap. +2.24%+5.53%+42.31%+83.29%

Financials

2024 2025
Net sales 688M 101M 88.58M 81.41M 75.88M 144M 9.65B 146M 977M 380M 4.74B 380M 372M 16.34B 925M 136M 119M 109M 102M 193M 12.97B 196M 1.31B 511M 6.37B 511M 500M 21.97B
Net income 20.5M 3.02M 2.64M 2.43M 2.26M 4.29M 287M 4.35M 29.12M 11.32M 141M 11.33M 11.09M 487M 81.67M 12.03M 10.52M 9.67M 9.01M 17.09M 1.15B 17.35M 116M 45.11M 563M 45.16M 44.19M 1.94B
Net Debt 58.68M 8.64M 7.56M 6.95M 6.47M 12.28M 823M 12.47M 83.38M 32.41M 405M 32.45M 31.75M 1.39B -72.61M -10.7M -9.35M -8.59M -8.01M -15.19M -1.02B -15.42M -103M -40.11M -501M -40.15M -39.29M -1.73B
Logo Teyi Pharmaceutical Group Co.,Ltd
Teyi Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of traditional Chinese medicine preparations, chemical pharmaceutical preparations, and chemical raw materials. The Company's products cover respiratory system, cardiovascular system, digestive system, dermatology, pediatrics, tonics, hypoglycemic agents, and wind-dispelling and dampness-removing agents. The Company's main products include Zhikebao Pian, Ganmaoling Keli, Yinxingye Fensanpian, Yixinshu Keli, Hydrotalcite Chewable Tablets, Omeprazole Enteric Capsules and others. The Company primarily conducts its businesses in domestic market.
Employees
1,434
Date Price Change Volume
26-07-03 CN¥9.370 -0.21% 31,171,777
26-07-02 CN¥9.390 -2.29% 44,170,419
26-07-01 CN¥9.610 +5.03% 55,557,705
26-06-30 CN¥9.150 +3.98% 52,292,430
26-06-29 CN¥8.800 +10.00% 18,930,303

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002728 Stock